menu
    • menu

    Company profile for Proxygen

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    With its numerous prestigious scientific institutes, Vienna is the intellectual home of Proxygen. Collaborations, know-how, and talent are never more than a few steps away, and the proximity to a wide range of biotech startups facilitates efficient synergies. At the same time, via its wide-reaching network, Proxygen is connected to major science hubs across Europe. Proxygen is a Vienna-based startup that develops therapies aga...
    With its numerous prestigious scientific institutes, Vienna is the intellectual home of Proxygen. Collaborations, know-how, and talent are never more than a few steps away, and the proximity to a wide range of biotech startups facilitates efficient synergies. At the same time, via its wide-reaching network, Proxygen is connected to major science hubs across Europe. Proxygen is a Vienna-based startup that develops therapies against cancer and other life-threatening diseases by reprogramming the cellular protein quality control system.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ProxygenAustria Flag
    Country
    Country
    Austria
    Address
    Address
    Dr.-Bohr-Gasse 7, VBC6 1030 Vienna
    Telephone
    Telephone
    +43 (0)1 226 1030
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://proxygen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/proxygen/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Proxigen, EPFL Partner for AI-Powered Glue Discovery
    Proxigen, EPFL Partner for AI-Powered Glue Discovery

    26 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/26/3139189/0/en/Proxygen-and-EPFL-Launch-Strategic-Collaboration-to-Advance-AI-Driven-Glue-Discovery.html

    GLOBENEWSWIRE
    26 Aug 2025
    Share Share
    Proxygen Announces Formation of Scientific Advisory Board
    Proxygen Announces Formation of Scientific Advisory Board

    15 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/15/2780899/0/en/Proxygen-Announces-Formation-of-Scientific-Advisory-Board.html

    GLOBENEWSWIRE
    15 Nov 2023
    Share Share
    Fierce Biotech Names Proxygen a €œFierce 15€ Biotech Company of 2023
    Fierce Biotech Names Proxygen a €œFierce 15€ Biotech Company of 2023

    28 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/08/28/2732414/0/en/Fierce-Biotech-Names-Proxygen-a-Fierce-15-Biotech-Company-of-2023.html

    GLOBENEWSWIRE
    28 Aug 2023
    Share Share
    Proxygen inks $2.5B deal with Merck & Co. as collabs stack up
    Proxygen inks $2.5B deal with Merck & Co. as collabs stack up

    06 Apr 2023

    // Max Bayer FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/proxygen-inks-deal-merck-co-worth-more-25-billion-averaging-new-collab-every-10-months

    Max Bayer FIERCE BIOTECH
    06 Apr 2023
    Share Share
    Proxygen Announces Agreement with MSD for Novel Molecular Glue Degraders
    Proxygen Announces Agreement with MSD for Novel Molecular Glue Degraders

    05 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/05/2641521/0/en/Proxygen-Announces-Collaboration-and-License-Agreement-with-MSD-for-the-Discovery-and-Development-of-Novel-Molecular-Glue-Degraders.html

    GLOBENEWSWIRE
    05 Apr 2023
    Share Share
    Proxygen Announces Formation of Board of Directors
    Proxygen Announces Formation of Board of Directors

    15 Mar 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/03/15/2627494/0/en/Proxygen-Announces-Formation-of-Board-of-Directors.html

    GLOBENEWSWIRE
    15 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search